Swedana Samsakara of Haritaki (Terminalia chebula Retz) with Jala and Gomutra: A comparative Phyto-Pharmacognostical study
Samsakara (transformation) and Samyoga (combination) play major role in pharmaceutics. Samsakara is defined as Gunantaradhanam (transformation). Swedana is Agni Sannikarsha Samsakara. The changes in finished product because of Swedana Samsakara with two different media Jala and Gomutra can be perceived at pharmacognostical and phytochemical levels. Aims: To compare role of Swedana Samsakara with two different media Jala and Gomutra on basis of phyto-pharmacognostical, HPTLC and UV-VIS-NIR Reflectance (180-2500nm) study. Materials and Methods: In the present study, 3 samples were prepared viz. Haritaki Churna (Powder) (GH-1), Gomutra Swedita Haritaki(GH-3) and Jala Swedita Haritaki (GH-5), to compare role of Swedana Samsakara on basis of Pharmacognostical (powder microscopy), Pharmaceutical, HPTLC densitogram and UV-VIS-NIR reflectance (180-2500nm) study. Results: The samples prepared with different media showed difference in pharmacognostical, pharmaceutical, HPTLC and UV-VIS-NIR findings. Gomutra Swedita Haritaki(GH-3) had highest variation in all Phyto-Pharmacognostical, HPTLC and UV-VIS-NIR. Powder microscopy of GH-3 showed clumped epicarp cells, squashed mesocarp cells (not clear), parenchyma cells with brown content, cellular content was darker (brown) and crystalline material etc. Phytochemical parameters showed pH (7.0), loss on drying (9.303%w/w), ash value (15.84%w/w), water soluble extract (57.2%w/w), and alcohol soluble extract (43.5% w/w). HPTLC showed eight peaks at 256nm and 366nm. In UV-VIS-NIR, GH-3 has higher variation while other sample has higher leverage. GH-3 has apparent different profile from GH-1, GH-5. Conclusions: Swedana Samsakara effect was seen in both Jala and Gomutra but media (Samyoga) plays leading role to establish desired Gunas (qualities) and Karma (therapeutic action) in the final product.
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.